DVA DaVita
Updated
Healthcare · Services-Misc Health & Allied Services, Nec
DaVita (DVA) is a healthcare company in the Services-Misc Health & Allied Services, Nec industry, with a market capitalization of $11.6 billion. Shares last traded at $181.84, 26.5% below their 52-week high. Over the past year the stock is up 33.7%. DVA trades at a price-to-earnings ratio of 13.69, below the Services-Misc Health & Allied Services, Nec median of 24.83. Net profit margin is 6.0%, in line with the peer median of 6.0%. Revenue grew 6.5% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $6.86 | 2026-08-04 |
| Q1 2026 | $2.87 | 2026-05-05 |
| FY 2025 | $9.84 | 2026-02-11 |
| Q3 2025 | $6.62 | 2025-10-29 |
| Q2 2026 | $4.57 | 2026-08-04 |
| Q1 2026 | $2.00 | 2026-05-05 |
Services-Misc Health & Allied Services, Nec peers
DVA vs 11 industry peers (Services-Misc Health & Allied Services, Nec), by market cap. Updated
| DVA | DaVita | $11.6B | 13.69 | 0.83 | 6.0% | +1.37% |
| SHC | Sotera Health Co | $5.4B | 33.24 | 4.47 | 13.4% | +0.37% |
| PGNY | Progyny, Inc. | $2.0B | 25.98 | 1.56 | 6.0% | +1.31% |
| AGL | Agilon Health, Inc. | $1.4B | -6.24 | 0.24 | -3.9% | -1.43% |
| VMD | VIEMED HEALTHCARE, INC. | $343M | 23.67 | 1.14 | 4.8% | +0.22% |
| PARK | Park Dental Partners, Inc. | $97M | — | — | — | -2.47% |
| CCEL | CRYO CELL INTERNATIONAL INC | $34M | -13.70 | 1.09 | -7.9% | +0.24% |
| MGRX | MANGOCEUTICALS, INC. | $8M | -0.56 | 26.91 | — | +0.86% |
| BRTX | BioRestorative Therapies, Inc. | $4M | -0.33 | 10.18 | — | -29.73% |
| NIVF | NewGenIvf Group Ltd | — | — | — | — | -7.44% |
| FMS | Fresenius Medical Care Ag | — | — | — | 23.6% | -0.82% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.